(Q35095248)

6 August 2017

1 reference

title

Treatment perspectives for human African trypanosomiasis (English)

1 reference

6 August 2017

0 references

African trypanosomiasis

0 references

author name string

Bernard Bouteille

1

1 reference

6 August 2017

Odile Oukem

2

1 reference

6 August 2017

Sylvie Bisser

3

1 reference

6 August 2017

Michel Dumas

4

1 reference

6 August 2017

publication date

1 April 2003

1 reference

Fundamental and Clinical Pharmacology

6 August 2017

published in

1 reference

6 August 2017

volume

17

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

171-181

1 reference

Human African trypanosomiasis: an emerging public health crisis

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

Re-emergence of epidemic sleeping sickness in southern Sudan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

The situation of sleeping sickness in Angola: a calamity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

Sleeping sickness resurgence in the DRC: the past decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

The duality of sleeping sickness: focusing on sleep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

Characterization of Trypanosoma brucei brucei S-adenosyl-L-methionine decarboxylase and its inhibition by Berenil, pentamidine and methylglyoxal bis(guanylhydrazone).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

Polyamine and pentamidine metabolism in African trypanosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

Pentamidine concentrations in plasma, whole blood and cerebrospinal fluid during treatment of Trypanosoma gambiense infection in Côte d'Ivoire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

Pharmacokinetics and adverse reactions after a single dose of pentamidine in patients with Trypanosoma gambiense sleeping sickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

Long-term exposure of Trypanosoma brucei gambiense to pentamidine in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

Present status of chemotherapy and chemopropylaxis of human trypanosomiasis in the Eastern Hemisphere

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

Localization of nine glycolytic enzymes in a microbody-like organelle in Trypanosoma brucei : The glycosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

Purification, morphometric analysis, and characterization of the glycosomes (microbodies) of the protozoan hemoflagellate Trypanosoma brucei

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

Inhibition of the glycolytic enzymes in the trypanosome: an approach in the development of new leads in the therapy of parasitic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

Uptake of the trypanocidal drug suramin by bloodstream forms of Trypanosoma brucei and its effect on respiration and growth rate in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

Risk factors for treatment failure after melarsoprol for Trypanosoma brucei gambiense trypanosomiasis in Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

Human trypanosomiasis in the Ivory Coast: therapy and problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

Risk factors for encephalopathy and mortality during melarsoprol treatment of Trypanosoma brucei gambiense sleeping sickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

Four years' experience of melarsen oxide/BAL in the treatment of late-stage Rhodesian sleeping sickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

Polyamine depletion following exposure to DL-alpha-difluoromethylornithine both in vivo and in vitro initiates morphological alterations and mitochondrial activation in a monomorphic strain of Trypanosoma brucei brucei

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

Treatment of gambiense sleeping sickness in the Sudan with oral DFMO (DL-alpha-difluoromethylornithine), an inhibitor of ornithine decarboxylase; first field trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

Efficacy and toxicity of eflornithine for treatment of Trypanosoma brucei gambiense sleeping sickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

The disposition of antiparasitic drugs in relation to the development of resistance by parasites of livestock

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

Future prospects for the chemotherapy of human trypanosomiasis. 1. Novel approaches to the chemotherapy of trypanosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

Trypanothione metabolism and rational approaches to drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

An open clinical trial of nifurtimox for arseno-resistant Trypanosoma brucei gambiense sleeping sickness in central Zaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

High-dose nifurtimox for arseno-resistant Trypanosoma brucei gambiense sleeping sickness: an open trial in central Zaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

New drugs for the treatment of human African trypanosomiasis: research and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

Suramin/metronidazole combination for African sleeping sickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

The trypanocidal effect of drugs in different parts of the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

Combination chemotherapy of CNS trypanosomiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

The story of CGP 40 215: studies on its efficacy and pharmacokinetics in African green monkey infected with Trypanosoma brucei rhodesiense

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

Trypanocidal activity of dicationic compounds related to pentamidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

Megazol combined with suramin: a chemotherapy regimen which reversed the CNS pathology in a model of human African trypanosomiasis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

Treatment of human African trypanosomiasis--present situation and needs for research and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

Blood–cerebrospinal fluid barrier and intrathecal immunoglobulins compared to field diagnosis of central nervous system involvement in sleeping sickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

Progress in Human African Trypanosomiasis, Sleeping Sickness

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

Therapy of human African trypanosomiasis: current situation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

Synthesis and activity of inhibitors highly specific for the glycolytic enzymes from Trypanosoma brucei

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1472-8206.2003.00167.X

10.1046/J.1472-8206.2003.00167.X

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference